TRIUMPH restatrutide program, design and schedule : rationale and design of Phase 3 retatrutide trials for obesity, OSA and osteoarthritis
results may be slower than injections Injectable Peptides Best for: BPC-157, TB-500, GHK-Cu (subcutaneous) Advantages: Higher bioavailability, systemic benefits beyond hair (skin, joints, healing), faster onset of action Limitations: Requires injection protocol, not suitable for everyone, may need to be administered by a healthcare professional The Combination Approach Many practitioners and biohackers report the best results by combining topical and injectable peptides
Pro tip: Log weekly scale readings and schedule periodic BodySpec DEXA scans to objectively measure changes in your body composition
Score of (110) indicates mild problem, (1120) indicates moderate problem, (2130) indicates severe problem, (3140) indicates very severe problem 16
TL;DR Farxiga (dapagliflozin) and Ozempic (semaglutide) are both widely prescribed diabetes medications, but they belong to different drug classes and serve different clinical priorities